Exendin-4 (GLP-1R agonist) attenuated the effect of ANG II-induced hypertension in mice (33) and in vitro GLP-1 effectively inhibited ANG II-induced mesangial cell damage (34). This evidence concerns the gene GLP1R and hypertensive disorder.